Design of an innovative clinical development program using randomized controlled phase 2 trial data and real-world evidence from an expanded access protocol to assess mifomelatide (TCMCB07) in GI cancer cachexia.
Allison Gardner, Barry A. Badeau, Meghan Joly, William Riedl et autres